title: Sunitinib-induced pseudoprogression after whole-brain radiotherapy for metastatic renal cell carcinoma.
authors.affiliation: Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Kelly
authors.forename: Stephanie E
authors.initials: SE
authors.lastname: Weiss
authors.forename: David J
authors.initials: DJ
authors.lastname: Sher
authors.forename: Antonio R
authors.initials: AR
authors.lastname: Perez-Atayde
authors.forename: Paola
authors.initials: P
authors.lastname: Dal Cin
authors.forename: Toni K
authors.initials: TK
authors.lastname: Choueiri
mesh_terms: D000293:Adolescent; D000328:Adult; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000556:secondary*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000532:radiotherapy / Q000556:secondary*; D003131:Combined Modality Therapy / Q000009:adverse effects; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D009362:Neoplasm Metastasis; D011758:Pyrroles / Q000009:adverse effects*; D000077210:Sunitinib
chemical_list: D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib